About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, July 17th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

MediJane Holdings, Inc. (MJMD)

Investors Alley, Investopedia, StreetAuthority Financial, Dividend Opportunities, Trade of the Week, Insider Wealth Alert, and Oakshire News Bulletin reported recently on MediJane Holdings, Inc. (MJMD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

MediJane Holdings, Inc. markets and distributes products within the medical marijuana industry, including transdermal patches, capsules, sublingual sprays, oral strips, and other medical delivery systems as part of the Company’s strategic alliances with Phoenix Bio Pharmaceuticals. The design of MediJane’s products are to give doctors the ability to provide patients accurate and effective doses of cannabinoids to manage and treat pain and other specific illnesses. MediJane Holdings lists on the OTCQB.

On March 21, 2014, the Company entered into a License Agreement with Phoenix Bio Pharmaceuticals a Colorado-based developer of medical cannabinoid products and delivery systems for the treatment and management of illnesses. With this License Agreement, MediJane Holdings acquired an exclusive North American license for all intellectual property (IP), processes, and expertise related to certain medicinal cannabinoid products and delivery systems developed by Phoenix Bio Pharmaceuticals.

The licensing agreement extends to additional products or active ingredients sourced by Phoenix Bio Pharmaceuticals via its affiliates and third party suppliers and licensors. In addition, MediJane will have the right to sublicense the rights and to use Phoenix Bio Pharmaceuticals’ copyrights for marketing and distribution purposes. 

The Company’s products include the non-drowsy "Daytime Pain plus CBD" oral capsule, the CannaMist cannabinoid spray, and the MediStrip Relaxation oral strips. These have been formulated for the treatment of inflammation and chronic, neuropathic, arthritic, and back pain. These are smokeless alternatives and they provide accurate dosages and are part of the Company’s launch into the chronic pain management market. Regarding the MediStrip Relaxation tongue strip, this product allows the licensed patient to discretely manage their condition as recommended by their doctor. 
 

This week, MediJane Holdings announced that it completed the final formulation of its new Canna Liniment product line of topical analgesics. Canna Liniment is formulated for chronic pain and muscle soreness. It will give pain sufferers another unique cannabinoid delivery system option. The Canna Liniment product is a Chinese-style liniment. It is made with cannabis oil, wintergreen essential oil, and menthol.

MediJane Holdings, Inc. (MJMD), closed Thursday's trading session at $0.80, even for the day, on 961,703 volume with 476 trades. The average volume for the last 60 days is 115,177 and the stock's 52-week low/high is $0.216/$1.60.

Active Health Foods, Inc. (AHFD)

PennyStocks24, TopHotPennyStocksNow.com, HotStocksPenny, BestTopPennyStocksNow, HotTopPennyStocks, Greenbackers, Pennybuster, HotPennyStocksToday, BestPennyStocksNow, RockingStocks.com, Featured Profiles, and NicksPennyPicks.com reported recently on Active Health Foods, Inc. (AHFD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2008, Active Health Foods, Inc. develops and markets organic energy bars in the U.S. The Company’s principal business goal is to provide competitively priced, premium quality, organic energy bars. Active Health Foods developed the brand name "Active X™" for its energy bars. The term "Active X™" was trademarked by the Company on May 6, 2008. In addition, the Company has its all natural sparkling, flavored, "Sugar Free" soft drinks.

Active X Energy Bars are made with high quality 100 percent Organic “Certified”, 100 percent natural ingredients. These are Gluten Free “Certified”, Soy free, Non GMO, and Kosher and Vegan “Certified”. The Company’s energy bars are made from a proprietary formula developed by and exclusive to them. Active Health Foods offers its moist energy bars in Almond Chocolate Delight, Peanut Butter Chocolate Joy, Cashew Berry Dream, and Coconut Cocoa Passion flavors under the Active X brand name.

Each energy bar is 1.8 net ounces and comes wrapped in a distinct, decorated, full color wrapping. Each flavor is packaged into a full color decorated display box. This box is specifically designed to be used as a counter display for the retailer. The Company’s plan is to sell its products to retailers, including health food stores, gyms, grocery retail outlets, and convenience stores. Moreover, its plan is to sell to distributors.

Active Health Foods has launched a new company under the Active Health Foods umbrella named Tandem. Tandem has created a pioneering and proprietary system and the system has been beta tested and is ready to be implemented. Tandem’s system will take the encumbrance of finding leads off of Direct Sales companies through providing them with customers and distributors, giving them more time for selling and increasing volume.

In early June, Active Health Foods announced that Queathem & Associates, Inc. of Irvine, California is now under contract with Active Health Foods as Its Broker and Sale Agent for regional and national distribution. Some of the relationships that Queathem & Associates will leverage are Drug Chains such as Rite Aid and Walgreens, Convenience Store Chains such as Circle K and 7-Eleven, and Wholesale companies Costco and Sam's Club, among others.

Active Health Foods, Inc. (AHFD), closed Thursday's trading session at $0.0003, down 25.00%, on 128,583,664 volume with 61 trades. The average volume for the last 60 days is 7,656,562 and the stock's 52-week low/high is $0.0003/$0.50.

Applied DNA Sciences, Inc. (APDN)

SuperNova Elite, Top Stock Tips, and Investor Ideas reported on Applied DNA Sciences, Inc. (APDN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Applied DNA Sciences, Inc. is a provider of botanical-DNA based anti-counterfeiting technology and product authentication solutions. These solutions can help protect products, brands, and the intellectual property (IP) of companies, governments, and consumers from theft, counterfeiting, fraud and diversion. The Company’s SigNature® DNA describes the uncopyable marker that is at the center of all of its security and authentication solutions. Applied DNA Sciences is based in Stony Brook, New York. The Company’s shares trade on the OTC Markets’ OTCQB.

SigNature® DNA is at the core of its family of products. The foundation of SigNature® DNA is on full, double-stranded plant DNA. The Company does not use single-stranded, “synthetic” DNA. The mark will not wash off, even in aggressive industrial treatment baths. In addition, results are not hidden or obscured by false positives. SigNature® DNA markers can be used to strengthen brand protection efforts; mark, track and convict criminals; as well as strengthen supply chain security.   

Applied DNA Sciences’ products include digitalDNA®. This is a security tool, which uses the flexibility of mobile communications, the instant accessibility of secure, cloud-based data, and the absolute certainty of DNA to make item tracking and authentication quick, easy, and definitive. Additionally, products include DNAnet® forensic tagging systems. DNAnet intruder tagging systems help to expand and strengthen any security effort through providing a way of directly linking criminals to crimes.

Another product Applied DNA Sciences offers is fiberTyping® textile genotyping. FiberTyping® is a DNA test developed in collaboration with Supima (representing U.S. pima cotton growers) to provide a way to verify original ELS cotton content present in cotton products. In March 2014, the Company announced that the US Patent and Trademark Office (USPTO) issued patent no. 8,669,079 for Applied DNA Sciences’ fiberTyping® authentication of cotton-based products.

This week, Applied DNA Sciences noted that the Missile Defense Agency awarded the Company a research project that would expand Applied DNA Sciences’ technology platform established in the Phase I Small Business Innovation Research (SBIR) contract to accommodate as many as 100 electronic component manufacturers. The contract provides for monthly payments to the Company totaling approximately $975,000 over a two year period.

Applied DNA Sciences, Inc. (APDN), closed Thursday's trading session at $0.121, up 0.08%, on 542,082 volume with 54 trades. The average volume for the last 60 days is 841,017 and the stock's 52-week low/high is $0.084/$0.199.

Trans-Pacific Aerospace Company, Inc. (TPAC)

Pumps and Dumps, PennyStocks24, MajorPennyStocks, PennyStocks Forever, Penny Stocks VIP, Top Best Pennystocks, VIP Penny Stocks, Simply Best Penny Stocks, FatCat Stocks, and OTCEquity reported on Trans-Pacific Aerospace Company, Inc. (TPAC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Based in San Marino, California, Trans-Pacific Aerospace Company, Inc. designs, engineers and manufactures self-lubricating spherical bearings for commercial aircraft. The Company has planned product extensions using similar proprietary technology into maritime, power plant, as well as space applications. The Company formerly went by the name Pinnacle Energy Corp. It changed its name to Trans-Pacific Aerospace Company, Inc. in March of 2010. Trans-Pacific Aerospace lists on the OTCQB.

The Company’s intention is to use its proprietary aerospace bearing technologies to manufacture and sell component parts for new commercial aircraft and spares for the existing commercial fleet, at first through a joint venture in China. China is the largest market for commercial jetliners outside of the United States.

So far, Trans-Pacific Aerospace’s operations have centred on assisting its Chinese subsidiary, Godfrey (China) Ltd., in the development of its production facility in Guangzhou, China, and the design and engineering of Godfrey’s initial product line of spherical bearings. Godfrey has a special operating license granted by China's Ministry of Science and Technology. Godfrey has obtained SAE parts qualification of its facility in Guangzhou.

The Trans-Pacific Aerospace manufacturing facility will make aerospace quality SAE-AS 81820, 81934 and 81935 plain spherical bearings, bushings and rod-ends. The design of these components are to reduce friction and "bear" loads.

In September 2013, Trans-Pacific Aerospace announced that its Chinese subsidiary, Godfrey Guangzhou Aerospace Bearings (Godfrey), received additional SAE-AS81820 bearing and SAE-AS81935 bushing approvals from NAVAIR. This achievement is a milestone event for the Company. It will allow it to offer a larger catalog of qualified products to an industry estimated to triple in size over the next 20 years. Godfrey is the only manufacturer in China qualified to make bearings under SAE-AS81820 and SAE-AS81934 standards.

In May, Trans-Pacific Aerospace announced that it signed a Letter of Intent (LOI) with AVIC Harbin Bearing Corporation, Ltd. to form a joint venture to produce plain spherical bearings and to improve manufacturing methodology for all bearings. Furthermore, the Company will advise AVIC Harbin on management and operations.

Trans-Pacific Aerospace Company, Inc. (TPAC), closed Thursday's trading session at $0.0178, down 5.82%, on 147,000 volume with 4 trades. The average volume for the last 60 days is 194,083 and the stock's 52-week low/high is $0.0105/$0.08.

Revolutions Medical Corp. (RMCP)

BUYINS.NET, OtcWizard, Penny Dreamers, TradeThesePicks, Investors News Source, Penny Stocks VIP, and AllPennyStocks reported previously on Revolutions Medical Corp. (RMCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Based in Charleston, South Carolina, Revolutions Medical Corp. involves in the design, development, and commercialization of auto retractable vacuum safety syringes. The Company’s commitment is to developing and distributing new products and tools for the medical industry, whether internally or by way of acquisitions. It operates in two areas. One is safety-engineered medical devices, including its RevVac™ safety syringe. The other is medical imaging enhancement. This includes proprietary software solutions that considerably enhance the ability of medical professionals to use standard MRI images for diagnosis assistance.

Revolutions Medical’s RevVac™ safety syringe uses vacuum technology to retract the needle into the plunger after use. The syringe cannot be reused once the vacuum is activated. The Company believes that its safety syringe should essentially eliminate accidental needle stick injuries. In Addition, it believes it will help in reducing the spread of contagious diseases. The Company also believes that with the help of government regulatory initiatives and individual state law reforms the safety syringe market will grow in the foreseeable future domestically and worldwide.

Revolutions Medical is working on developing, enhancing, and securing its proprietary MRI software tools for commercial launch. It believes that once clinical application validations using its MRI software suite of products, including RevColor, RevDisplay, and Rev3D directed at concussions, stroke, Alzheimer's and breast disease are achieved, these products could ultimately help in the enhanced diagnosis, detection, and monitoring of such diseases and afflictions.

Revolutions Medical has started sales of its 3ml RevVac™ safety syringe through introducing and signing distributors, advertisements via its online sales program, attendance at many industry trade shows and direct marketing campaigns. It expects to be in full scale production by the third quarter of 2014 for its 1ml, 5ml and 10ml RevVac™ safety syringes. When all sizes of the RevVac™ safety syringe are in production, the Company believes that it can ship 50 million RevVac™ safety syringes for the following twelve month period.

Recently, Revolutions Medical announced that it received notification that its auto retractable vacuum safety syringe patent was granted and issued in Australia, and its patent claims were accepted and will be granted and issued in Taiwan. Revolutions Medical now has five countries in which the RevVac™ safety syringe has additional international patent protection outside of the U.S. This includes China, Japan, and Mexico. 

Revolutions Medical Corp. (RMCP), closed Thursday's trading session at $0.0084, down 5.62%, on 74,100 volume with 4 trades. The average volume for the last 60 days is 883,627 and the stock's 52-week low/high is $0.0054/$0.079.

graphic

The QualityStocks
Company Corner

graphic
graphic

WordLogic Corp. (WLGC)

The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.0999, up 4.39%, on 11,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 66,631, and its 52-week low/high is $0.065/$0.26.

WordLogic Corp. filed a patent infringement lawsuit on July 14, 2014 against TouchType Ltd. d/b/a SwiftKey. The lawsuit alleges that SwiftKey infringes WordLogic's US patent number 8552984 entitled "Method, System, Apparatus and Computer-Readable Media For Directing Input Associated with Keyboard-Type Device."

WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.

The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.

For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.

Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer

WordLogic Corp. Company Blog

WordLogic Corp. News:

WordLogic Files Patent Infringement Lawsuit Against TouchType Ltd., Makers of SwiftKey

WordLogic Announces Development of iOS 8 Version of Award-Winning iKnowU Keyboard

WordLogic Engages in Venture Discussions With Prominent Mobile App Provider

Banjo & Matilda (BANJ)

The QualityStocks Daily Newsletter would like to spotlight Banjo & Matilda (BANJ). Today, Banjo & Matilda closed trading at $0.36, up 16.13%, on 107,292 volume with 44 trades. The stock’s average daily volume over the past 60 days is 13,756, and its 52-week low/high is $0.102/$0.51.

Banjo & Matilda (BANJ) is an emerging Australian lifestyle brand known globally for its fun sweaters and luxe cashmere basics. Big on quality and small on pretense, the company’s cashmere sweaters are spun with natural and ethically sourced yarns from goats in the highest mountains of Inner Mongolia, putting a little bespoke love into each garment with their signature XX logo hand-stitched into each right-hand corner.

Founders Belynda and Ben Macpherson wanted to create sweaters that were not only discreetly luxurious, but also captured the freedom of their lifestyle by the beach—the freshness of the ocean, warmth of the sand and soulfulness of the surf—in a range of knitwear made with supreme quality and integrity. The result being sweaters spun from the most premium of natural yarns such as fine cashmere, silk and organic cotton but supporting the opposite of “fast-fashion” in sustainability, longevity, endurance and lovability.

The brand, which has a rapidly growing loyal following, is quickly being stocked in important major and specialty retailers around the world, including Net-a-Porter, Shopbop, Harvey Nichols London, Neiman Marcus, Intermix New York, David Jones Australia and major department stores in Germany and the Middle East. Apparel is also shipped in other locations of the world through Banjo Matilda’s online store to loyal customers from Bondi to New Delhi.

Banjo & Matilda’s long-term vision is to grow distribution similarly to peers in the industry such as Vince Holding Corp. (NYSE: VNCE), which is now in more than 2,100 retail outlets, and Zadig & Voltair, which shares a similar growth pattern to the company. In just one quarter this year, Banjo & Matilda increased the number of retail outlets “doors” stocking its products by 122%. By September, the company is expected to increase the number of outlets by 433% from Q4 2013 based upon forward wholesale orders received. Disclaimer

Banjo & Matilda Company Blog

Banjo & Matilda News:

Banjo & Matilda Reports Record Wholesale Sales For Its Fall/Winter Seasons

Banjo & Matilda Appoints Leading U.S. Fashion Sales Agency To Grow Distribution

Banjo & Matilda Grows Retailer Outlet Distribution in First Quarter by 122%

5BARz International, Inc. (BARZ)

The QualityStocks Daily Newsletter would like to spotlight 5BARz International, Inc. (BARZ). Today, 5BARz International, Inc. closed trading at $0.21, up 10.53%, on 110,250 volume with 14 trades. The stock’s average daily volume over the past 60 days is 80,481, and its 52-week low/high is $0.08/$0.35.

5BARz International, Inc. (BARZ) is engaged in the design, development and global commercialization of new technologies that enable cellular network carriers to improve the connectivity performance endemic on their networks and provide clear, high-quality signal for their subscribers. Cellular industry data shows that more than 3% of mobile subscribers leave one network for a competing network specifically because of poor signal quality, dropped calls and weak data. By addressing the global demand for high-quality service, 5Barz seeks to capitalize on the minimum market opportunity of approximately $27 billion created by subpar cellular infrastructure.

At the core of this mission is the company’s patented product technology, 5BARz™, a cellular network infrastructure device for use in the small office, home or for when users are mobile. 5BARz has incorporated this patented technology to create a highly engineered, single-piece, plug 'n play unit that strengthens weak cellular signals and delivers high-quality signals for voice, data and video reception on cell phones and other cellular-equipped devices.

Current cellular network infrastructure is comprised of cell towers, cellular base stations, macro repeaters, micro cells, and many other “carrier grade” technologies and categories. 5BARz aims to revolutionize this network infrastructure with its one-of-a-kind and industry first 5Barz Network Extender™ product. This entirely new category will allow network operators the ability to position or “extend” a new and critical piece of their network infrastructure directly into the homes and offices of its subscribers to deliver a stronger, more reliable cellular single.

5Barz Network Extender was launched in February, 2014, in Barcelona during the Mobile World Congress, and garnered widespread and extremely positive feedback that confirmed the company’s belief that the industry is looking for a solution to improve coverage in poor coverage areas within their networks. 5Barz™ represents a critical solution with the potential to fundamentally change the way cellular carrier network infrastructure is designed and deployed to their billions of subscribers worldwide. Disclaimer

5BARz International, Inc. Company Blog

5BARz International, Inc. News:

5BARz Invites You To Follow Them On Equities.com

5Barz Taps David Kovacs for Corporate Development

5BARz Issues Letter to Shareholders

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.195, up 30.00%, on 850 volume with 2 trades. The stock’s average daily volume over the past 60 days is 9,288, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. Highlights Recent Media Coverage of MRSA

Zenosense, Inc. Provides Development Update

Zenosense, Inc. Extends License to Include Cancer Applications

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0368, up 10.18%, on 81,942 volume with 5 trades. The stock’s average daily volume over the past 60 days is 490,535, and its 52-week low/high is $0.032/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Launches Development of Solar Ecommerce Marketplace for India

Pan Global, Corp. Commences Design Phase for Planned Hydroponic Greenhouse in Northern India

Pan Global, Corp. Shareholder Update: Anticipated Two Stage Completion of Small-Hydro Plant and Connection to Power Grid

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CBYI)

2.

Real Pennies
(SWCC)

3.

Jet-Life Penny Stocks
(TNEN)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251